As co-receptors of TCR, CD4+ or CD8+ cells can recognize MHC-II molecules on the surface of tumor cells or APC [71], respectively, and these two molecules can act as the first signal of T cell activation to activate T cells through the MHC-I pathway. The gene discussed is CD8A; the disease is neoplasm.